BR112018074910A2 - composição imunológica, e, método de indução de uma resposta imunológica contra o vírus da influenza equina em um sujeito - Google Patents

composição imunológica, e, método de indução de uma resposta imunológica contra o vírus da influenza equina em um sujeito

Info

Publication number
BR112018074910A2
BR112018074910A2 BR112018074910-9A BR112018074910A BR112018074910A2 BR 112018074910 A2 BR112018074910 A2 BR 112018074910A2 BR 112018074910 A BR112018074910 A BR 112018074910A BR 112018074910 A2 BR112018074910 A2 BR 112018074910A2
Authority
BR
Brazil
Prior art keywords
influenza virus
inducing
subject
immune response
equine influenza
Prior art date
Application number
BR112018074910-9A
Other languages
English (en)
Inventor
Martinez-Sobrido Luis
Original Assignee
University Of Rochester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of Rochester filed Critical University Of Rochester
Publication of BR112018074910A2 publication Critical patent/BR112018074910A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1018—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16161—Methods of inactivation or attenuation
    • C12N2760/16162—Methods of inactivation or attenuation by genetic engineering

Abstract

a presente invenção proporciona composições e métodos relacionados com vacinas do vírus da influenza equina vivo atenuado.
BR112018074910-9A 2016-06-03 2017-06-02 composição imunológica, e, método de indução de uma resposta imunológica contra o vírus da influenza equina em um sujeito BR112018074910A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662345293P 2016-06-03 2016-06-03
US62/345293 2016-06-03
PCT/US2017/035630 WO2017210528A1 (en) 2016-06-03 2017-06-02 Equine influenza virus live-attenuated vaccines

Publications (1)

Publication Number Publication Date
BR112018074910A2 true BR112018074910A2 (pt) 2019-03-12

Family

ID=59351046

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018074910-9A BR112018074910A2 (pt) 2016-06-03 2017-06-02 composição imunológica, e, método de indução de uma resposta imunológica contra o vírus da influenza equina em um sujeito

Country Status (8)

Country Link
US (1) US10857224B2 (pt)
EP (1) EP3463439B1 (pt)
JP (1) JP2019520338A (pt)
CN (1) CN109414488A (pt)
BR (1) BR112018074910A2 (pt)
CA (1) CA3026256A1 (pt)
MX (1) MX2018014955A (pt)
WO (1) WO2017210528A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA42656A (fr) 2015-08-20 2018-06-27 Univ Cornell Vaccin vivant atténué comprenant des mutations de polymérase virale pour le traitement et la prévention de virus de la grippe canine
EP3463439B1 (en) * 2016-06-03 2022-08-03 University of Rochester Equine influenza virus live-attenuated vaccines
CA3087239A1 (en) * 2018-02-27 2019-09-06 University Of Rochester Multivalent live-attenuated influenza vaccine for prevention and control of equine influenza virus (eiv) in horses
US20220133877A1 (en) * 2019-02-27 2022-05-05 University Of Rochester Multivalent Live-attenuated Influenza Vaccine for Prevention and Control of Equine Influenza Virus (EIV) in Horses

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166057A (en) 1989-08-28 1992-11-24 The Mount Sinai School Of Medicine Of The City University Of New York Recombinant negative strand rna virus expression-systems
US5854037A (en) 1989-08-28 1998-12-29 The Mount Sinai School Of Medicine Of The City University Of New York Recombinant negative strand RNA virus expression systems and vaccines
EP1394259A3 (en) 1994-07-18 2004-04-14 Karl-Klaus Prof. Dr. Conzelmann Recombinant infectious non-segmented negative strand RNA virus
US7153510B1 (en) 1995-05-04 2006-12-26 Yale University Recombinant vesiculoviruses and their uses
EP0780475B2 (en) 1995-08-09 2006-07-19 SCHWEIZ. SERUM- & IMPFINSTITUT BERN Process for the production of infectious negative-strand RNA viruses
WO1997012032A1 (en) 1995-09-27 1997-04-03 The Government Of The United States Of America, As Represented By The Department Of Health And Human Services Production of infectious respiratory syncytial virus from cloned nucleotide sequences
AU3799797A (en) 1996-07-15 1998-02-09 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
WO1998013501A2 (en) 1996-09-27 1998-04-02 American Cyanamid Company 3' genomic promoter region and polymerase gene mutations responsible for attenuation in viruses of the order designated mononegavirales
ATE501259T1 (de) 1997-05-23 2011-03-15 Us Of America As Represented By The Secretary Of The Dept Of Health And Human Services Herstellung attenuierter parainfluenza-virus impfstoffe aus klonierten nukleotidsequenzen
CA2295858C (en) 1997-07-11 2011-05-10 Yale University Rhabdoviruses with reengineered coats
CN1273603A (zh) 1997-09-19 2000-11-15 美国氰胺公司 减毒的呼吸道合胞病毒
US7425336B2 (en) 2005-08-25 2008-09-16 Mevial Limited Canine influenza vaccines
NZ566490A (en) 2005-10-07 2011-06-30 Pfizer Prod Inc Live attenuated or killed H3N8 influenza vaccines and methods to treat canine influenza
US8475807B2 (en) * 2008-03-13 2013-07-02 University Of Maryland College Park Avian influenza virus live attenuated vaccine and uses thereof
WO2011044561A1 (en) 2009-10-09 2011-04-14 The Research Foundation Of State University Of New York Attenuated influenza viruses and vaccines
US8457807B2 (en) * 2010-08-18 2013-06-04 International Business Machines Corporation Thermal relationships based workload planning
EP2751260A2 (en) * 2011-09-02 2014-07-09 Westfälische Wilhelms-Universität Münster Live attenuated influenza virus
EP3022298B1 (en) * 2013-07-19 2019-06-19 University Of Rochester Attenuated influenza vaccines and uses thereof
WO2017031408A1 (en) 2015-08-20 2017-02-23 University Of Rochester Single-cycle virus for the development of canine influenza vaccines
MA42656A (fr) 2015-08-20 2018-06-27 Univ Cornell Vaccin vivant atténué comprenant des mutations de polymérase virale pour le traitement et la prévention de virus de la grippe canine
EP3463439B1 (en) * 2016-06-03 2022-08-03 University of Rochester Equine influenza virus live-attenuated vaccines

Also Published As

Publication number Publication date
EP3463439B1 (en) 2022-08-03
JP2019520338A (ja) 2019-07-18
US10857224B2 (en) 2020-12-08
WO2017210528A1 (en) 2017-12-07
CA3026256A1 (en) 2017-12-07
EP3463439A1 (en) 2019-04-10
CN109414488A (zh) 2019-03-01
MX2018014955A (es) 2019-05-13
US20190125860A1 (en) 2019-05-02

Similar Documents

Publication Publication Date Title
MX2018007627A (es) Vacuna contra el virus del zika.
EA201800108A1 (ru) Вакцинные композиции для профилактики абровирусных инфекций
BR112018013387A2 (pt) vetor de vacinação recombinante, vírus mva, vacina ou composição farmacêutica e kit
CL2019003805A1 (es) Composiciones inmunógenas de senecavirus a y métodos de éstas.
MX2017001406A (es) Agentes a base de flagelina y usos de los mismos, incluyendo vacunación efectiva.
CL2018002874A1 (es) Anticuerpos de hemaglutinina contra el virus de la influenza b y métodos de uso (divisional de solicitud n° 2413-2016).
PH12018000197A1 (en) Hand, foot, and mouth vaccines and methods of manufacture and use thereof
PH12017501370A1 (en) Bivalent swine influenza virus vaccine
CO6551750A2 (es) Vacuna del virus del dengue inactivado que incluye un adyuvante sin aluminio
BR112018074910A2 (pt) composição imunológica, e, método de indução de uma resposta imunológica contra o vírus da influenza equina em um sujeito
MY194449A (en) Zika vaccines and immunogenic compositions, and methods of using the same
MX2021010060A (es) Produccion de virus en huevos aviares.
MX2015010305A (es) Vacuna de combinacion para virus sincitial respiratorio e influenza.
BR112018075440A2 (pt) composições e métodos para prevenir e tratar a infecção por zika vírus
BR112017004197A2 (pt) composições de vacina contra doenças do vírus da dengue
MX2016016746A (es) Composiciones de vacuna con adyuvante dual, preparacion y usos.
MX2017002803A (es) Coronavirus bovino atenuado y vacunas relacionadas.
BR112016024096A2 (pt) novo bacteriófago e composição compreendendo o mesmo
MX2017016896A (es) Vacunas inactivadas contra la influenza canina, metodos para elaborarlas y sus usos.
EA201991377A1 (ru) Композиции универсальной вакцины против гриппа
MX2020005554A (es) Vacunas y composiciones inmunogenas para zika y metodos para usarlas.
MX2019005102A (es) Poxvirus quimericos sinteticos.
BR112018010679A2 (pt) métodos para tratar, prevenir e diagnosticar a infecção por vírus da diarréia epidêmica porcina
BR112017002440A2 (pt) vírus da diarreia epizoótica porcina mutante para utilização em uma vacina
EP3305328A4 (en) Non-gelatin vaccine protectant composition and live attenuated influenza vaccine

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements